PARIS – The president of the French Agency for the fight against doping (AFLD), Pierre Bordry, said Thursday he was “very impressed” by the work of U.S. authorities investigating the case of Lance Armstrong who is being accused of doping by his former teammate Floyd Landis.
The seven-time Tour de France rider is the target of an investigation by two U.S. attorneys and the U.S. Anti-Doping Agency (USADA), following a confession by the disgraced rider Floyd Landis, who had his 2006 Tour de France title stripped from him.
“If U.S. prosecutors or the U.S. Agency asked us something in the context of mutual legal assistance, of course we will,” said president of the AFLD, at a press conference.
“We have close cooperation with the Agency, and it does not date from yesterday. Today, we are almost continuous relationship with them,” he said, without wanting to say more.
“I am very impressed by the quality of working Americans in this area, especially the American agency,” he added simply.
Several blood and urine samples from Armstrong are kept in France. Those from the Tour de France in 1999 which contain the EPO, according to a story conducted by the newspaper L’Equipe in 2005, are sealed judicial doping laboratory of Chatenay-Malabry. For these samples, the limitation period for sporting sanctions – at eight years by the World Anti-Doping Code – is now outdated.